Concepts (186)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neoplastic Syndromes, Hereditary | 4 | 2024 | 70 | 1.120 |
Why?
|
| Medulloblastoma | 6 | 2019 | 340 | 0.880 |
Why?
|
| Early Detection of Cancer | 5 | 2019 | 356 | 0.850 |
Why?
|
| Cerebellar Neoplasms | 6 | 2019 | 285 | 0.800 |
Why?
|
| von Hippel-Lindau Disease | 2 | 2023 | 19 | 0.780 |
Why?
|
| Genetic Predisposition to Disease | 11 | 2025 | 3133 | 0.670 |
Why?
|
| Whole Body Imaging | 1 | 2017 | 29 | 0.580 |
Why?
|
| Li-Fraumeni Syndrome | 1 | 2017 | 42 | 0.570 |
Why?
|
| Paraganglioma | 1 | 2017 | 19 | 0.570 |
Why?
|
| Pheochromocytoma | 1 | 2017 | 34 | 0.560 |
Why?
|
| Wilms Tumor | 3 | 2024 | 113 | 0.540 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 2017 | 66 | 0.540 |
Why?
|
| Beckwith-Wiedemann Syndrome | 2 | 2024 | 16 | 0.450 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2017 | 719 | 0.430 |
Why?
|
| Germ-Line Mutation | 5 | 2025 | 333 | 0.410 |
Why?
|
| Glutathione S-Transferase pi | 1 | 2012 | 25 | 0.410 |
Why?
|
| Hearing Loss | 2 | 2017 | 132 | 0.400 |
Why?
|
| Radiotherapy | 1 | 2012 | 136 | 0.380 |
Why?
|
| Palatal Neoplasms | 1 | 2011 | 5 | 0.380 |
Why?
|
| Connexins | 1 | 2011 | 59 | 0.370 |
Why?
|
| Oropharyngeal Neoplasms | 1 | 2011 | 163 | 0.320 |
Why?
|
| Hepatoblastoma | 2 | 2024 | 180 | 0.310 |
Why?
|
| DNA Methylation | 3 | 2019 | 1000 | 0.280 |
Why?
|
| PTEN Phosphohydrolase | 2 | 2020 | 260 | 0.270 |
Why?
|
| Brain Neoplasms | 3 | 2024 | 1245 | 0.270 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2011 | 656 | 0.260 |
Why?
|
| Child | 20 | 2025 | 24515 | 0.250 |
Why?
|
| Ribonuclease III | 2 | 2017 | 89 | 0.250 |
Why?
|
| DEAD-box RNA Helicases | 2 | 2017 | 121 | 0.240 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2015 | 2614 | 0.230 |
Why?
|
| Mutation | 5 | 2020 | 5807 | 0.230 |
Why?
|
| Retinoblastoma | 1 | 2025 | 110 | 0.220 |
Why?
|
| Retinal Neoplasms | 1 | 2025 | 100 | 0.220 |
Why?
|
| Kidney Neoplasms | 2 | 2024 | 430 | 0.200 |
Why?
|
| Practice Guidelines as Topic | 4 | 2025 | 1263 | 0.200 |
Why?
|
| Gadolinium | 1 | 2021 | 104 | 0.180 |
Why?
|
| Humans | 28 | 2025 | 124326 | 0.170 |
Why?
|
| DNA Polymerase II | 1 | 2019 | 19 | 0.170 |
Why?
|
| Poly-ADP-Ribose Binding Proteins | 1 | 2019 | 29 | 0.160 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2020 | 79 | 0.160 |
Why?
|
| Adolescent | 11 | 2020 | 19354 | 0.160 |
Why?
|
| Cisplatin | 2 | 2017 | 242 | 0.160 |
Why?
|
| Vascular Malformations | 1 | 2020 | 87 | 0.160 |
Why?
|
| Neurofibroma, Plexiform | 1 | 2018 | 7 | 0.160 |
Why?
|
| Neovascularization, Pathologic | 1 | 2020 | 240 | 0.150 |
Why?
|
| Neurofibromin 1 | 1 | 2018 | 42 | 0.150 |
Why?
|
| Genotype | 4 | 2022 | 2552 | 0.150 |
Why?
|
| Neurofibromatosis 1 | 1 | 2018 | 61 | 0.150 |
Why?
|
| Fumarate Hydratase | 1 | 2017 | 2 | 0.140 |
Why?
|
| Jaw Neoplasms | 1 | 2017 | 4 | 0.140 |
Why?
|
| Leiomyomatosis | 1 | 2017 | 7 | 0.140 |
Why?
|
| Proto-Oncogene Proteins c-ret | 1 | 2017 | 29 | 0.140 |
Why?
|
| Thyroid Neoplasms | 1 | 2020 | 198 | 0.140 |
Why?
|
| Child, Preschool | 10 | 2020 | 14075 | 0.140 |
Why?
|
| Multiple Endocrine Neoplasia | 1 | 2017 | 22 | 0.140 |
Why?
|
| Hamartoma Syndrome, Multiple | 1 | 2017 | 20 | 0.140 |
Why?
|
| Hyperparathyroidism | 1 | 2017 | 24 | 0.140 |
Why?
|
| Antigens, Nuclear | 1 | 2017 | 61 | 0.140 |
Why?
|
| p21-Activated Kinases | 1 | 2017 | 58 | 0.140 |
Why?
|
| Fibroma | 1 | 2017 | 30 | 0.140 |
Why?
|
| Sacroiliac Joint | 1 | 2016 | 5 | 0.140 |
Why?
|
| Neurofibrosarcoma | 1 | 2016 | 5 | 0.140 |
Why?
|
| Xeroderma Pigmentosum Group D Protein | 1 | 2016 | 21 | 0.130 |
Why?
|
| Sacrum | 1 | 2016 | 29 | 0.130 |
Why?
|
| Spinal Nerve Roots | 1 | 2016 | 26 | 0.130 |
Why?
|
| Pelvic Bones | 1 | 2016 | 27 | 0.130 |
Why?
|
| Liver Neoplasms | 2 | 2024 | 1319 | 0.130 |
Why?
|
| Glioma | 1 | 2021 | 500 | 0.130 |
Why?
|
| Uterine Neoplasms | 1 | 2017 | 107 | 0.130 |
Why?
|
| Language Development Disorders | 1 | 2017 | 173 | 0.130 |
Why?
|
| Haploinsufficiency | 1 | 2017 | 257 | 0.130 |
Why?
|
| Adenoma | 1 | 2017 | 135 | 0.130 |
Why?
|
| Infant | 8 | 2023 | 12474 | 0.130 |
Why?
|
| DNA, Neoplasm | 1 | 2016 | 301 | 0.130 |
Why?
|
| Ear Diseases | 1 | 2015 | 18 | 0.130 |
Why?
|
| Craniofacial Abnormalities | 1 | 2017 | 242 | 0.120 |
Why?
|
| Population Surveillance | 1 | 2017 | 389 | 0.120 |
Why?
|
| Superoxide Dismutase | 1 | 2015 | 139 | 0.120 |
Why?
|
| Pineal Gland | 1 | 2014 | 19 | 0.120 |
Why?
|
| Pinealoma | 1 | 2014 | 21 | 0.120 |
Why?
|
| Microcephaly | 1 | 2017 | 332 | 0.120 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2017 | 467 | 0.110 |
Why?
|
| Female | 13 | 2020 | 66264 | 0.110 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2017 | 549 | 0.110 |
Why?
|
| Young Adult | 5 | 2020 | 8978 | 0.110 |
Why?
|
| Colorectal Neoplasms | 1 | 2019 | 566 | 0.110 |
Why?
|
| Neoplasm Proteins | 1 | 2017 | 669 | 0.100 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2017 | 1000 | 0.100 |
Why?
|
| Genetic Testing | 3 | 2025 | 1004 | 0.100 |
Why?
|
| Neuroectodermal Tumors, Primitive | 1 | 2012 | 52 | 0.100 |
Why?
|
| Male | 12 | 2020 | 60987 | 0.100 |
Why?
|
| Diagnosis, Differential | 1 | 2017 | 1887 | 0.100 |
Why?
|
| Connexin 26 | 1 | 2011 | 13 | 0.100 |
Why?
|
| Immunohistochemistry | 2 | 2012 | 1684 | 0.090 |
Why?
|
| Abnormalities, Multiple | 1 | 2017 | 964 | 0.090 |
Why?
|
| Nerve Tissue Proteins | 1 | 2017 | 1113 | 0.090 |
Why?
|
| Risk Factors | 4 | 2017 | 10139 | 0.090 |
Why?
|
| Disease-Free Survival | 1 | 2012 | 860 | 0.090 |
Why?
|
| Fatal Outcome | 1 | 2011 | 356 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 19 | 1 | 2010 | 59 | 0.090 |
Why?
|
| Abdominal Neoplasms | 1 | 2010 | 33 | 0.090 |
Why?
|
| Thiolester Hydrolases | 1 | 2010 | 9 | 0.090 |
Why?
|
| Carcinoma, Small Cell | 1 | 2010 | 50 | 0.090 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2021 | 3576 | 0.090 |
Why?
|
| Lymphatic Metastasis | 1 | 2011 | 402 | 0.090 |
Why?
|
| I-kappa B Kinase | 1 | 2010 | 61 | 0.080 |
Why?
|
| Skin Neoplasms | 1 | 2017 | 803 | 0.080 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2012 | 1017 | 0.080 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2011 | 141 | 0.080 |
Why?
|
| Chromosomes, Human, X | 1 | 2010 | 157 | 0.080 |
Why?
|
| Genetic Variation | 1 | 2015 | 1492 | 0.080 |
Why?
|
| Biomarkers, Tumor | 1 | 2016 | 1460 | 0.080 |
Why?
|
| Neoplasms | 1 | 2022 | 2794 | 0.070 |
Why?
|
| NF-kappa B | 1 | 2010 | 459 | 0.070 |
Why?
|
| Transcription Factors | 1 | 2017 | 2607 | 0.070 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2010 | 671 | 0.070 |
Why?
|
| Retinoblastoma Binding Proteins | 1 | 2025 | 11 | 0.060 |
Why?
|
| Phenotype | 3 | 2020 | 4255 | 0.060 |
Why?
|
| DNA Mutational Analysis | 2 | 2019 | 788 | 0.060 |
Why?
|
| Australia | 1 | 2024 | 138 | 0.060 |
Why?
|
| Adult | 3 | 2020 | 29378 | 0.050 |
Why?
|
| Genetic Association Studies | 2 | 2018 | 775 | 0.050 |
Why?
|
| Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2023 | 35 | 0.050 |
Why?
|
| Respiratory Syncytial Viruses | 1 | 2003 | 147 | 0.050 |
Why?
|
| Fibroblast Growth Factors | 1 | 2003 | 153 | 0.050 |
Why?
|
| Patients | 1 | 2023 | 121 | 0.050 |
Why?
|
| Prognosis | 2 | 2020 | 4554 | 0.040 |
Why?
|
| DNA Mismatch Repair | 1 | 2019 | 48 | 0.040 |
Why?
|
| Follow-Up Studies | 2 | 2020 | 5106 | 0.040 |
Why?
|
| Leukocyte Count | 1 | 2019 | 247 | 0.040 |
Why?
|
| Germ Cells | 1 | 2019 | 195 | 0.040 |
Why?
|
| Cohort Studies | 2 | 2017 | 4730 | 0.040 |
Why?
|
| Middle Aged | 1 | 2017 | 26442 | 0.040 |
Why?
|
| Retrospective Studies | 3 | 2021 | 16223 | 0.040 |
Why?
|
| Multiple Endocrine Neoplasia Type 2b | 1 | 2017 | 4 | 0.040 |
Why?
|
| Contrast Media | 1 | 2021 | 476 | 0.040 |
Why?
|
| Antineoplastic Agents | 2 | 2017 | 1674 | 0.030 |
Why?
|
| Lymphocytes | 1 | 2019 | 406 | 0.030 |
Why?
|
| Larva | 1 | 2017 | 248 | 0.030 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 1 | 2017 | 89 | 0.030 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2017 | 120 | 0.030 |
Why?
|
| Mass Screening | 1 | 2022 | 784 | 0.030 |
Why?
|
| Neutrophils | 1 | 2019 | 378 | 0.030 |
Why?
|
| Europe | 1 | 2017 | 352 | 0.030 |
Why?
|
| Sequence Deletion | 1 | 2018 | 528 | 0.030 |
Why?
|
| Heterozygote | 1 | 2018 | 676 | 0.030 |
Why?
|
| Incidence | 1 | 2023 | 3086 | 0.030 |
Why?
|
| Medical Oncology | 1 | 2017 | 215 | 0.030 |
Why?
|
| Gene Editing | 1 | 2017 | 193 | 0.030 |
Why?
|
| CpG Islands | 1 | 2016 | 323 | 0.030 |
Why?
|
| Infant, Newborn | 2 | 2020 | 8183 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2019 | 1320 | 0.030 |
Why?
|
| Zebrafish | 1 | 2017 | 389 | 0.030 |
Why?
|
| CRISPR-Cas Systems | 1 | 2017 | 261 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2019 | 1400 | 0.030 |
Why?
|
| Mutation, Missense | 1 | 2018 | 868 | 0.030 |
Why?
|
| Family Health | 1 | 2014 | 259 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 1 | 2016 | 1341 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2017 | 3050 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 2019 | 2055 | 0.020 |
Why?
|
| Alleles | 1 | 2015 | 1614 | 0.020 |
Why?
|
| Yin-Yang | 1 | 2010 | 1 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2017 | 2303 | 0.020 |
Why?
|
| Brain | 1 | 2021 | 3004 | 0.020 |
Why?
|
| Ubiquitination | 1 | 2010 | 174 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2015 | 3268 | 0.020 |
Why?
|
| HeLa Cells | 1 | 2010 | 809 | 0.020 |
Why?
|
| Translocation, Genetic | 1 | 2010 | 356 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 2010 | 414 | 0.020 |
Why?
|
| Texas | 1 | 2016 | 3590 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2010 | 701 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 1288 | 0.020 |
Why?
|
| Neurons | 1 | 2017 | 1966 | 0.020 |
Why?
|
| Cell Line | 1 | 2010 | 2770 | 0.010 |
Why?
|
| Virus Inactivation | 1 | 2003 | 9 | 0.010 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 2003 | 26 | 0.010 |
Why?
|
| Dactinomycin | 1 | 2003 | 67 | 0.010 |
Why?
|
| Respiratory Sounds | 1 | 2003 | 69 | 0.010 |
Why?
|
| Bronchi | 1 | 2003 | 98 | 0.010 |
Why?
|
| Epidermal Growth Factor | 1 | 2003 | 122 | 0.010 |
Why?
|
| United States | 1 | 2017 | 10766 | 0.010 |
Why?
|
| Cell Survival | 1 | 2003 | 806 | 0.010 |
Why?
|
| Virus Replication | 1 | 2003 | 609 | 0.010 |
Why?
|
| Respiratory Syncytial Virus Infections | 1 | 2003 | 341 | 0.010 |
Why?
|
| Epithelial Cells | 1 | 2003 | 911 | 0.010 |
Why?
|
| Animals | 1 | 2017 | 34134 | 0.010 |
Why?
|